Molecular Analysis For Qualitative Detection of Sars-Cov-2.: Negative Negative Negative Pass

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4

Reg. No : KS180696 Reg.

Date : 13-03-2021 09:11 AM Collected On : 13-03-2021 07:51 PM


Name : Mr. _______________ Report Date : 13-03-2021
Age : 24 Sex : Male Dispatch At :
Ref. By : ___________________ Tele No : 80800 45451
Location : Mumbai

Parameter Result Unit Biological Refernce Interval

MOLECULAR ANALYSIS FOR QUALITATIVE DETECTION OF SARS-CoV-2.


Type of sample : Nasopharyngeal swab and Oropharyngeal swab.
Methodology : Real time Qualitative RT-PCR.
ICMR NO : DJLD001

 ORF 1ab Negative


 N Gene Negative
 S Gene Negative
 MS2 GENE Pass
(Internal Control)

Interpretation
 2019-nCoV NEGATIVE

Note :
 Test report should be correlated with the clinical presentation and findings.
 The LOD for the three target genes is 10 copies/reactions.
 A negative result does not rule out 2019-nCoV and should not be used on the sole basis for treatment or other patient management decisions.
 A number of factors could lead to a negative in an infected individual including
o Poor quality of the specimen, containing inadequate patient material or non-representative specimen.
o The specimen wan collected late or very early in the infection. Optimum specimen types and timing for peak viral levels during infections caused by
2019-nCoV have not been determined. Collection of multiple samples from the same patient may be necessary to detect the virus.
o The specimen was not handed and shipped appropriately.
o Technical reasons inherent in the test, e.g. Virus mutation or PCR inhibition.
o Inadequate numbers of organisms are present in the specimen.
 Reports will be provided to the treating physician who in requested to communicate the same to the patent and follow MOHFW policy tor isolation,
quarantine and treatment of all positive cases along with contact tracing as recommended.
 Repeat sampling and testing of lower respiratory specimen in strongly recommended in severe or progressive disease.
 The repeat specimen may be considered after gap of 2 – 4 days after the collection of the first specimen for additional testing if required.
 Categories of viral load is based on Cycle threshold (Ct) detected by RT PCR.
1. High Viral Load : 17 to 24
2. Moderate Viral Load : 24 to 30
3. Low/Mild Viral Load : 31 to 38.

------------------- End Of Report ---------------------


Reg. No : KS180696 Reg. Date : 20-04-2021 09:11 AM Collected On : 22-04-2021 07:51 PM
Name : Mr. Keval Manish Shah Report Date : 20-04-2021
Age : 24 Sex : Male Dispatch At :
Ref. By : Dr. Vinod Birajdar Tele No : 80800 45451
Location : Mumbai
Reg. No : TS061196 Reg. Date : 11-08-2021 09:11 AM Collected On : 12-08-2021 12:51 PM
Name : Ms. Twinkle Solanki Report Date : 12-08-2021
Age : 24 Sex : Female Dispatch At : 12-08-2021
Ref. By : Self Tele No : +91 96195 55907
Location : Dehradun District

Parameter Result Unit Biological Refernce Interval

MOLECULAR ANALYSIS FOR QUALITATIVE DETECTION OF SARS-CoV-2.


Type of sample : Nasopharyngeal swab and Oropharyngeal swab.
Methodology : Real time PCR.
ICMR NO :UNIPA001

 ORF 1ab Negative


 N Gene Negative
 S Gene Negative
 MS2 GENE Pass
(Internal Control)

Interpretation
 2019-nCoV NEGATIVE

Note :
 Test report should be correlated with the clinical presentation and findings.
 The LOD for the three target genes is 10 copies/reactions.
 A negative result does not rule out 2019-nCoV and should not be used on the sole basis for treatment or other patient management decisions.
 A number of factors could lead to a negative in an infected individual including
o Poor quality of the specimen, containing inadequate patient material or non-representative specimen.
o The specimen wan collected late or very early in the infection. Optimum specimen types and timing for peak viral levels during infections caused by
2019-nCoV have not been determined. Collection of multiple samples from the same patient may be necessary to detect the virus.
o The specimen was not handed and shipped appropriately.
o Technical reasons inherent in the test, e.g. Virus mutation or PCR inhibition.
o Inadequate numbers of organisms are present in the specimen.
 Reports will be provided to the treating physician who in requested to communicate the same to the patent and follow MOHFW policy tor isolation,
quarantine and treatment of all positive cases along with contact tracing as recommended.
 Repeat sampling and testing of lower respiratory specimen in strongly recommended in severe or progressive disease.
 The repeat specimen may be considered after gap of 2 – 4 days after the collection of the first specimen for additional testing if required.
 Categories of viral load is based on Cycle threshold (Ct) detected by RT PCR.
4. High Viral Load : 17 to 24
5. Moderate Viral Load : 24 to 30
6. Low/Mild Viral Load : 31 to 38.

------------------- End Of Report ---------------------

HELPLINE: 0135-2430942 / 2439551-54 For feedback: [email protected] www.nirmalhospitals.com


Address: Nirmal Ashram Hospital, Mayakund, Rishikesh-249 201, Distt. Dehradun (UK), India.
Disclaimer: 1) Please note that laboratory results serve as an aid to diagnosis and should be interpreted in relation to clinical findings. Please refer back to the laboratory if there is
any discrepancy between clinical and laboratory diagnosis. 2) (i) Part of this test report can’t be produced without written approval of lab (ii) The test samples are submitted by the
patient/picked up by the lab personnel. (iii) The report pertains to submitted samples only.
PATIENT’S NAME : MR. _______________ SAMPLE ID No. : 101162003

AGE / SEX : xx Years / M REPORT DATE : 13/03/2021 10:58AM

REF. BY DR. : SELF PRINT DATE : 13/03/2021 11:14AM


SAMPLE DATE / TIME : XX/XX/XXXX X:XXPM CENTRE : LAB

PERMANENT ID NO. : KS180696

You might also like